Hungary's Richter performs below expectations in Q1

No new record in sales this quarter

Hungary Richter eyes bond issuance

Participation in central bank programme pending BoD approval

Hungary Richter sets new records - What next?

Record revenue in Q4 2020, as well

Hungary receives coronavirus drug for ambulant treatment

Bamlanivimab to arrive on Wednesday

European Commission reaches decision on Hungarian Richter's Esmya

It may be used in the EU only in certain cases

EU signs deal with Moderna for 80 million dose of 94% effective COVID-19 vaccine

With option to buy another 80 million

CHMP recommends restricting the use of Richter's Esmya

Ball now in European Commission's court

Hungary Richter stakeholder crosses north of 5% threshold

Hungary to go on with COVID drug trial

Remdesivir research continues despite WHO statement

Hungary to test favipiravir coronavirus drug

Clinical trials begin in five locations

Sanofi Hungary to upgrade syringe plant for HUF 7 bn

Increasing capacity by 50%

ANALYST VIEW - Drug of Hungary's Richter could be facing new rival

Jefferies publishes opinion

EU, AstraZeneca sign deal on COVID-19 vaccine

British drugmaker to supply 300 mn doses

Hungarian state ownership in Richter decreases

Share transfer to foundation closed

ANALYST VIEW - Jefferies ups target price for Hungary's Richter

Share price close to all-time high

Richter receives marketing authorisation for Libdree in UK

Hungary Richter Q2 results beat expectations

Vraylar sales skyrockets, revenue rises

EU signs deal with Gilead to supply COVID-19 drug

EUR 63 mn for 30,000 doses of remdesivir

ANALYST VIEW - Jefferies reviews Richter 'wonder' drug

Vraylar sequential growth to continue after lockdown

EU approves Covid-19 drug remdesivir

Gilead’s Veklury first to get go-ahead